https://www.cochrane.org/evidence/CD001342_vitamin-k-antagonists-versus-antiplatelet-therapy-after-transient-ischaemic-attack-or-minor
Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor...
vitamin k antagoniststransient ischaemic attackantiplatelet therapy
https://pmc.ncbi.nlm.nih.gov/articles/PMC8370080/
European Stroke Organisation (ESO) guidelines on management of transient ischaemic attack - PMC
The aim of the present European Stroke Organisation Transient Ischaemic Attack (TIA) management guideline document is to provide clinically useful...
transient ischaemic attack
https://pmc.ncbi.nlm.nih.gov/articles/PMC4221669/
Transient ischaemic attack: a qualitative study of the long term consequences for patients - PMC
Transient ischaemic attack (TIA) is characterised by its transient nature with symptoms of neurological dysfunction resolving within 24 hours. The occurrence...
transient ischaemic attack